Author Archive
Bayer CEO warns pricing pressu…
Bayer CEO warns pricing pressure could affect development of new drugs http://t.co/28KwpXQx
GSK persuades NICE to reconsid…
GSK persuades NICE to reconsider negative Benlysta decision http://t.co/q7TPlmFF
UK government, ABPI to negotia…
UK government, ABPI to negotiate new drug pricing framework – FirstWord http://t.co/mj6zdzn4
ABPI choses a clear position w…
ABPI choses a clear position with respect to VBP, pointing to problematic price control aspects of VBP http://t.co/bLOqVFlJ
When you get beyond the positi…
When you get beyond the positive sounding “Value Based Pricing” phrase it does not make sense http://t.co/wRE50Nx1
Patients Wade into the Europea…
Patients Wade into the European Pricing Debate http://t.co/b6HnyIv4
When are EU politicians realiz…
When are EU politicians realizing that their parallel trade policies together with price controls for drugs are only c…http://t.co/mxGOhSXp
Rising co-pays in Spain may fu…
Rising co-pays in Spain may further change pricing dynamic in the market http://t.co/mxGOhSXp
US biotech warning over Europe…
US biotech warning over Europe price cuts | FirstWord Pharma http://t.co/9GaMz1X0
As double digit growth prospec…
As double digit growth prospects disappear and price cuts more commonplace in emerging markets, it is crucial that the…http://t.co/WAU803yX
Subscribe
Visit my LinkedIn profile, click on this button:
